IN A.G.: Congress Closed the Hemp Loophole, Indiana Must Too
Congress recently closed the hemp loophole allowing intoxicating delta-8 and delta-10 THC products from hemp. Indiana has yet to align state law with this federal change, creating regulatory gaps. Clinicians should be aware of the indiana hemp loophole…
Congressional Roadblocks Delay Hemp THC Ban (Newsletter: February 27, 2026)
Hemp THC regulatory delays continue to complicate the legal and clinical landscape in 2026. Congressional roadblocks have prolonged uncertainty around hemp-derived THC products. This delay impacts patient safety, clinical guidance, and federal oversight.
Bemidji Chamber Ambassadors welcome Coconut Cannabis
✦ New CED Clinical Relevance #15 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryHempCBD 💬 Join the Conversation Have a question about how this applies to your situation? Ask Dr. Caplan…
Indiana Won’t Ban Hemp THC Products This Year After Last-Minute Legislative Push Fails
Indiana hemp THC regulation remains unchanged after the legislature failed to ban hemp-derived THC products this year. This means patients will continue accessing unregulated hemp THC products in Indiana. Clinicians should counsel patients on the safety…
New Trump Tariffs Create Chaos and Uncertainty for Cannabis Operators
Cannabis supply disruption caused by new Trump tariffs is creating significant challenges for operators and patients alike. These tariffs increase costs and uncertainty in the cannabis market, impacting patient access to regulated products. Clinicians…
Amendment to Delay Hemp THC Ban Fails at Farm Bill Hearing
The federal hemp THC regulation impact is significant as the proposed amendment to delay the hemp THC ban failed to advance at the Farm Bill hearing. This maintains the current restrictions on hemp-derived THC products. Clinicians and patients face…
What 12 Weeks of Medicinal Cannabis Did for Endometriosis Pain
A 2026 medicinal cannabis endometriosis cohort study found a 31% reduction in pelvic pain and a 46% quality-of-life improvement over 12 weeks. Some patients discontinued opioids during the study. This research offers new clinical insights for…
Intoxicating Hemp Ban Unchanged in 2026 Farm Bill’s Advancement
The 2026 intoxicating hemp ban remains a key feature of the Farm Bill, maintaining federal restrictions on psychoactive hemp products. This ban affects cannabinoids such as delta-8 and delta-10 THC that fall outside hemp legalization. Clinicians face…
Cannabis, Beer, and Wellness: Meet Tilray Brands, Ireland’s Newest Publican – The Currency
Tilray Brands is making waves in the cannabis beer wellness market by acquiring pub operations in Ireland. This expansion highlights the cannabis industry's move into alcohol and wellness sectors. Clinicians should note the growing presence of cannabis…
R40bn Opportunity for Hemp Industrialisation in South Africa Requires Industry Development
The hemp industrialisation South Africa opportunity is valued at approximately R40bn, contingent on strategic industry development. Realizing this potential requires investment in infrastructure, processing capabilities, and regulatory frameworks. This…
